| Full Name | Wauligman Dentistry |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 7 South Road, Addyston, Ohio |
| Authorized Official Name and Position | Whitney R Wauligman (VICE PRESIDENT / OWNER) |
| Authorized Official Contact | 5136624242 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Wauligman Dentistry Po Box 489 Addyston OH 45001-0489 Ph: (513) 662-4242 | Wauligman Dentistry 7 South Road Addyston OH 45001 Ph: (513) 662-4242 |
| NPI Number | 1699113092 |
|---|---|
| Provider Enumeration Date | 06/06/2013 |
| Last Update Date | 12/13/2023 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699113092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | (* (Not Available)) | Primary |
News Archive
A person's risk of developing cancer is affected by genetic variations in regions of DNA that don't code for proteins, previously dismissed as ‘junk DNA', according to new research published in the British Journal of Cancer today (Friday).
The "Great Recession" may have put a dent in many older adults' pocketbooks, but a new study, which will be presented at the 109th Annual Meeting of the American Sociological Association, finds that more than 40 percent reported a decrease in "financial strain" between 2006 and 2010.
With the recognition that certain subgroups of the population seemed to have a higher risk of developing severe disease following infection, some countries put shielding policies into place to protect them from infection.
Ambry Genetics, a global leader in genomic services, announced today that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System as well as received the first 510(K) approved Illumina BeadXpress Genotyping System. Ambry Genetics has been an early adapter of Illumina systems since late 2007 and has extensive experience as a Certified Service Provider.
Brain-selective estrogen treatment improves the symptoms of Parkinson's disease in male mice, according to new research published in JNeurosci. These findings may help explain the sex differences in Parkinson's disease and could lead to estrogen-based treatments.
› Verified 4 days ago